Published
Interim results of Oxford University's Phase I/II trial of a COVID-19 vaccine were published today in the scientific journal, The Lancet.
They indicate no safety concerns, as well as T-cell and antibody responses against the SARS-CoV-2 virus, and neutralising antibody response. The trials will continue, in order to find out whether these responses are the type and strength needed to fight the virus.
Find out more about the vaccine: https://www.ox.ac.uk/covid-vaccine
They indicate no safety concerns, as well as T-cell and antibody responses against the SARS-CoV-2 virus, and neutralising antibody response. The trials will continue, in order to find out whether these responses are the type and strength needed to fight the virus.
Find out more about the vaccine: https://www.ox.ac.uk/covid-vaccine
- Category
- Academic
Sign in or sign up to post comments.
Be the first to comment
Up Next
Autoplay
-
25:50
COVID Conversations: Oxford's COVID-19 Government Response Tracker
-
00:50
WHO recommends Oxford vaccine against malaria
-
03:20
Oxford's COVID-19 vaccine is highly effective: Phase III trial interim results
-
10:36
Covid-19: Will vaccine be for all? News Review
-
06:18
COVID-19 coronavirus vaccine: everything you need to know
-
00:54
Human trial of new COVID-19 vaccine begins
-
00:55
The Black Death today: Oxford launches clinical trial of a plague vaccine
-
02:30
Oxford's scientists explain the Phase I/II results for the COVID-19 vaccine
-
34:09
The 5:30 A.M. Warrior Call: COVID-19 Vaccine to Begin Human Trial (4/07/2020)
-
04:01
What's a human challenge trial of COVID-19 like?
-
01:51
Coronavirus: How long will it take to develop a Covid-19 vaccine?
-
01:36
Cancer Vaccine Trial Starting on Patients
-
14:01
MMR Vaccine Was Approved After Small Studies With Disturbing Results
-
02:01
African Research, Oxford Vaccine
-
03:54
Why You Should Still Get The Vaccine If You've Already Had Covid | Dr. Ian Smith
-
00:48
Oxford University's 'vaccine for the world' is effective
-
02:12
COVID Vaccine: What are its greatest challenges?
-
00:49
Oxford launches trials for new oral vaccine against paratyphoid
-
11:05
Covid-19: Drug trial gives hope: BBC News Review
-
02:36
Human challenge trial to study immune response to COVID-19
-
01:00
The world's biggest randomised clinical trial of COVID-19 treatments is a year old
-
00:55
Oxford's malaria vaccine - The story so far
